Shamik Chakraborty MD

Neurosurgery•Princeton, NJ

Brain & Spinal Tumor, Neurosurgical Spine Surgery, Neurotrauma

Neurosurgeon at UPenn Princeton Medical Center, Capital Health System, Centrastate Medical Center

Join to View Full Profile

731 Alexander RoadSuite 200Princeton, NJ 08540
Phone+1 609-921-9001

Summary

Dr. Shamik Chakraborty is an award winning neurosurgeon practicing in New Jersey. He received his medical degree from State University of New York Downstate Medical Center College of Medicine, and neurosurgical training at Northwell Health. He specializes in brain & spinal tumors, neurosurgical spine surgery, and neurotrauma.

Education & Training

Zucker School of Medicine at Hofstra/NorthwellResidency, Neurological Surgery, 2012 - 2019
North Shore University Hospital - Northwell HealthFellowship, Neurosurgical Oncology, 2017
State University of New York Downstate Medical Center College of MedicineClass of 2012

Certifications & Licensure

PA State Medical License 2020 - 2026
NJ State Medical License Active through 2025
NY State Medical License Active through 2025

Clinical Trials

Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) Start of enrollment: 2009 Jul 01
Completed
Phase 1
Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA Start of enrollment: 2009 Dec 01
Completed
Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA Start of enrollment: 2010 Oct 01
Recruiting
Phase 1, Phase 2
Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM Start of enrollment: 2013 Feb 01
Completed
Phase 1, Phase 2
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2015 May 01
Terminated
Phase 1
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Start of enrollment: 2016 May 01
Recruiting
Phase 2
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma Start of enrollment: 2016 Jun 01
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Final Results of the Prospective Multicenter Excimer Laser-Assisted High-Flow Bypass Study on the Treatment of Giant Anterior Circulation Aneurysms
Albert van der Zwan, Peter Vajkoczy, Sepideh Amin-Hanjani, Fady T. Charbel, Babu G. Welch
Neurosurgery. 2020-09-15
37 citations
Technical Aspects and Operative Nuances Using a High-Definition 3-Dimensional Exoscope for Cerebral Bypass Surgery
Erez Nossek, Julia R Schneider, Kevin Kwan, Kay O Kulason, Victor Du
Operative Neurosurgery. 2019-08-01
Commentary: Surgical Outcomes Following Repeat Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas: A Retrospective Comparative Study.
Victor Du, Shamik Chakraborty, Amir R. Dehdashti
Operative Neurosurgery. 2019-02-01

Professional Memberships